References
- Al Sioufi H, Button L, Propper R, et al. A novel non-radio-active chromium method for red cell survival in humans (abstract). Transfusion 1985;25:415.
- AuBuchon JP, Brightman A. Use of Indium-111 as a red cell label. Transfusion 1989;29:143–7.
- Bentley SA, Collins ML, Miller DT. Interpretation of red cell survival data for in vivo compatibility testing: a normal value study. Br J Haematol 1987;67:241–4.
- Berlin NI. Determination of red cell life span. JAMA 1964;188:375–8.
- Chaplin H Jr, Coleman ME, Monroe MC. In vivo instability of red-blood-cell bound C3d and C4d. Blood 1983;62:965–71.
- 6. Davey RJ, Lenes BL, Casper AJ, et al. Red cells from units “undercollected” in CPDA-1 survive adequately after transfusion. Transfusion 1984;24:319–22.
- 7. Davey RJ. Red cell radiolabeling in transfusion medicine. In: Davey RJ, Wallace ME, eds. Diagnostic and investigational use of radiolabeled blood elements. Arlington, VA: American Association of Blood Banks, 1987:39–66.
- 8. Davey RJ. The uses of radiolabeled red cells in transfusion medicine. Transfusion Medicine Reviews 1988;2:151–60.
- 9. Donohue DM, Motulsky AG, Giblett ER, et al. The use of chromium as a red cell tag. Br J Haematol 1955;1:249.
- 10. Ebaugh EG, Emerson CP, Ross JF. The use of radioactive chromuim-51 as an erythrocyte-tagging agent for the determination of red cell survival